https://www.selleckchem.com/products/ABT-888.html
The CHA DS -VASC score has expanded its use beyond the initial purpose of predicting the risk of stroke in patients with atrial fibrillation. We aimed to investigate the value of the CHA DS -VASC score as a risk assessment tool to predict relevant coronary artery disease (CAD) leading to percutaneous coronary intervention (PCI), and all-cause mortality after detected ventricular arrhythmia (VA) in patients with an Implantable Cardioverter-Defibrillator(ICD). A total of 183 ICD-patients who underwent coronary angiography after VA were in
Like
Comment
Share
